ESR1 and breast cancer: For further confirmation of the involvement of CCN5 in activation and functionalresponse of ER-α in BC cells, we determined whether blocking CCN5 activityby CCN5-specific antibody treatment reduces the proliferative effect of E2 orimpede the effect of 4OH-Tam (4-hydroxy-tamoxifen) on MCF-7 cells.